Does AMBRISENTAN Cause Hypervolaemia? 205 Reports in FDA Database
Boost Your Natural Energy & Metabolism
Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.
According to the FDA Adverse Event Reporting System (FAERS), 205 reports of Hypervolaemia have been filed in association with AMBRISENTAN (AMBRISENTAN). This represents 0.2% of all adverse event reports for AMBRISENTAN.
205
Reports of Hypervolaemia with AMBRISENTAN
0.2%
of all AMBRISENTAN reports
20
Deaths
163
Hospitalizations
How Dangerous Is Hypervolaemia From AMBRISENTAN?
Of the 205 reports, 20 (9.8%) resulted in death, 163 (79.5%) required hospitalization, and 2 (1.0%) were considered life-threatening.
Is Hypervolaemia Listed in the Official Label?
This adverse event is not currently listed in the official FDA drug label for AMBRISENTAN. However, 205 reports have been filed with the FAERS database.
What Other Side Effects Does AMBRISENTAN Cause?
Dyspnoea (13,367)
Death (7,497)
Headache (7,325)
Pneumonia (4,693)
Dizziness (4,561)
Fatigue (4,436)
Diarrhoea (4,312)
Nausea (3,986)
Fluid retention (3,927)
Malaise (3,839)
What Other Drugs Cause Hypervolaemia?
TREPROSTINIL (580)
CALCIUM\DEXTROSE\MAGNESIUM\SODIUM\SODIUM (428)
MACITENTAN (202)
FUROSEMIDE (139)
AMLODIPINE (122)
CYCLOPHOSPHAMIDE (118)
SACUBITRIL\VALSARTAN (115)
TACROLIMUS (100)
PREDNISONE (98)
MYCOPHENOLATE MOFETIL (89)
Which AMBRISENTAN Alternatives Have Lower Hypervolaemia Risk?
AMBRISENTAN vs AMBROSIA ARTEMISIIFOLIA POLLEN
AMBRISENTAN vs AMBROXOL
AMBRISENTAN vs AMDINOCILLIN PIVOXIL
AMBRISENTAN vs AMG-510
AMBRISENTAN vs AMIFAMPRIDINE